On this page
Adbry
tralokinumab-ldrm
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Adbry
Proper name
tralokinumab-ldrm
Licence type
351(a)
BLA number
761180
Applicant
LEO Pharma A/S
Center
CDER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 150MG/ML | Injection | Subcutaneous | Pre-Filled Syringe | Rx | December 27, 2021 |
| 300MG/2ML | Injection | Subcutaneous | Autoinjector | Rx | June 12, 2024 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |